|
|
Other links at Articles > Obstetrics and Gynecology |
| 3. |
Many DCIS Patients Overestimate Recurrence Risk
|
|
|
Although the risk of recurrence after treatment for ductal carcinoma in situ (DCIS) is very small, most patients believe that their risk is at least moderate, according to a report in the Journal of the National Cancer Institute for February 20th. Reuters Health Information
|
| 5. |
Anastrozole Does Not Impair Cognition as Breast Cancer Preventative
|
|
|
Although there have been concerns that estrogen depletion might impair cognition in women with or at risk for breast cancer, the results of a new study suggest that prophylactic use of the aromatase inhibitor anastrazole does not have this effect. Reuters Health Information
|
|
|
